401 related articles for article (PubMed ID: 20684021)
1. The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease.
Rotman Y; Koh C; Zmuda JM; Kleiner DE; Liang TJ;
Hepatology; 2010 Sep; 52(3):894-903. PubMed ID: 20684021
[TBL] [Abstract][Full Text] [Related]
2. Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third National Health and Nutrition Examination Survey.
Hernaez R; McLean J; Lazo M; Brancati FL; Hirschhorn JN; Borecki IB; Harris TB; ; Nguyen T; Kamel IR; Bonekamp S; Eberhardt MS; Clark JM; Kao WH; Speliotes EK
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1183-1190.e2. PubMed ID: 23416328
[TBL] [Abstract][Full Text] [Related]
3. The Expression of PNPLA3 Polymorphism could be the Key for Severe Liver Disease in NAFLD in Hispanic Population.
Martínez LA; Larrieta E; Kershenobich D; Torre A
Ann Hepatol; 2017 November-December,; 16(6):909-915. PubMed ID: 29055919
[TBL] [Abstract][Full Text] [Related]
4. The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection.
Scheiner B; Mandorfer M; Schwabl P; Payer BA; Bucsics T; Bota S; Aichelburg MC; Grabmeier-Pfistershammer K; Stättermayer A; Ferenci P; Trauner M; Peck-Radosavljevic M; Reiberger T
PLoS One; 2015; 10(11):e0143429. PubMed ID: 26599080
[TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic fatty liver disease risk and histologic severity are associated with genetic polymorphisms in children.
Goyal NP; Rosenthal SB; Nasamran C; Behling CA; Angeles JE; Fishbein MH; Harlow KE; Jain AK; Molleston JP; Newton KP; Ugalde-Nicalo P; Xanthankos SA; Yates K; Schork NJ; Fisch KM; Schwimmer JB;
Hepatology; 2023 Jan; 77(1):197-212. PubMed ID: 35560106
[TBL] [Abstract][Full Text] [Related]
6. PNPLA3 rs738409 and risk of fibrosis in NAFLD: Exploring mediation pathways through intermediate histological features.
Vilar-Gomez E; Pirola CJ; Sookoian S; Wilson LA; Liang T; Chalasani N
Hepatology; 2022 Nov; 76(5):1482-1494. PubMed ID: 35349726
[TBL] [Abstract][Full Text] [Related]
7. PNPLA3 gene-by-visceral adipose tissue volume interaction and the pathogenesis of fatty liver disease: the NHLBI family heart study.
Graff M; North KE; Franceschini N; Reiner AP; Feitosa M; Carr JJ; Gordon-Larsen P; Wojczynski MK; Borecki IB
Int J Obes (Lond); 2013 Mar; 37(3):432-8. PubMed ID: 22546774
[TBL] [Abstract][Full Text] [Related]
8. GWAS and enrichment analyses of non-alcoholic fatty liver disease identify new trait-associated genes and pathways across eMERGE Network.
Namjou B; Lingren T; Huang Y; Parameswaran S; Cobb BL; Stanaway IB; Connolly JJ; Mentch FD; Benoit B; Niu X; Wei WQ; Carroll RJ; Pacheco JA; Harley ITW; Divanovic S; Carrell DS; Larson EB; Carey DJ; Verma S; Ritchie MD; Gharavi AG; Murphy S; Williams MS; Crosslin DR; Jarvik GP; Kullo IJ; Hakonarson H; Li R; ; Xanthakos SA; Harley JB
BMC Med; 2019 Jul; 17(1):135. PubMed ID: 31311600
[TBL] [Abstract][Full Text] [Related]
9. Patatin-like phospholipase domain-containing 3 gene (PNPLA3) polymorphic (rs738409) single nucleotide polymorphisms and susceptibility to nonalcoholic fatty liver disease: A meta-analysis of twenty studies.
Zhao Y; Zhao W; Ma J; Toshiyoshi M; Zhao Y
Medicine (Baltimore); 2023 Mar; 102(10):e33110. PubMed ID: 36897668
[TBL] [Abstract][Full Text] [Related]
10. The interaction of rs738409, obesity, and alcohol: a population-based autopsy study.
Dunn W; Zeng Z; O'Neil M; Zhao J; Whitener M; Yu-Jui Wan Y; Mitchell EK; Handler M; Weinman SA
Am J Gastroenterol; 2012 Nov; 107(11):1668-74. PubMed ID: 23032985
[TBL] [Abstract][Full Text] [Related]
11. A nutrigenetic precision approach for the management of non-alcoholic fatty liver disease.
Perez-Diaz-Del-Campo N; Dileo E; Castelnuovo G; Nicolosi A; Guariglia M; Caviglia GP; Rosso C; Armandi A; Bugianesi E
Clin Nutr; 2023 Nov; 42(11):2181-2187. PubMed ID: 37788561
[TBL] [Abstract][Full Text] [Related]
12. High red meat consumption among PNPLA3 polymorphism carriers is associated with NAFLD in a multi-center cross-sectional study.
Alvares-da-Silva MR; Ivancovsky-Wajcman D; Oliveira CP; Rabie S; Longo L; Uribe-Cruz C; Yoshimura SM; Joveleviths D; Ben-Yehoyada M; Grinshpan LS; Shibolet O; Kariv R; Zelber-Sagi S
Eur J Clin Nutr; 2024 May; 78(5):442-448. PubMed ID: 38403728
[TBL] [Abstract][Full Text] [Related]
13. The variability of PNPLA3 gene as a potential marker of cold adaptation in Yakuts.
Pavlova NI; Bochurov AA; Alekseev VA; Sydykova LA; Dodokhov VV; Kurtanov KA; Krylov AV
Int J Circumpolar Health; 2023 Dec; 82(1):2246647. PubMed ID: 37581274
[TBL] [Abstract][Full Text] [Related]
14. Characterization of European ancestry nonalcoholic fatty liver disease-associated variants in individuals of African and Hispanic descent.
Palmer ND; Musani SK; Yerges-Armstrong LM; Feitosa MF; Bielak LF; Hernaez R; Kahali B; Carr JJ; Harris TB; Jhun MA; Kardia SL; Langefeld CD; Mosley TH; Norris JM; Smith AV; Taylor HA; Wagenknecht LE; Liu J; Borecki IB; Peyser PA; Speliotes EK
Hepatology; 2013 Sep; 58(3):966-75. PubMed ID: 23564467
[TBL] [Abstract][Full Text] [Related]
15. Examining genetic associations with hepatic steatosis in Mexican-origin adults.
Trejo MJ; Morrill KE; Klimentidis YC; Garcia DO
Ann Hepatol; 2023; 28(5):101120. PubMed ID: 37271481
[TBL] [Abstract][Full Text] [Related]
16. Association between PNPLA3 (rs738409), LYPLAL1 (rs12137855), PPP1R3B (rs4240624), GCKR (rs780094), and elevated transaminase levels in overweight/obese Mexican adults.
Flores YN; Velázquez-Cruz R; Ramírez P; Bañuelos M; Zhang ZF; Yee HF; Chang SC; Canizales-Quinteros S; Quiterio M; Cabrera-Alvarez G; Patiño N; Salmerón J
Mol Biol Rep; 2016 Dec; 43(12):1359-1369. PubMed ID: 27752939
[TBL] [Abstract][Full Text] [Related]
17. Activin A levels in metabolic dysfunction-associated steatotic liver disease associates with fibrosis and the PNPLA3 I148M variant.
Jönsson C; Bergram M; Kechagias S; Nasr P; Ekstedt M
Scand J Gastroenterol; 2024 Jun; 59(6):737-741. PubMed ID: 38563432
[TBL] [Abstract][Full Text] [Related]
18. Individualized Polygenic Risk Score Identifies NASH in the Eastern Asia Region: A Derivation and Validation Study.
Gao F; Zheng KI; Chen SD; Lee DH; Wu XX; Wang XD; Targher G; Byrne CD; Chen YP; Kim W; Zheng MH
Clin Transl Gastroenterol; 2021 Mar; 12(3):e00321. PubMed ID: 33704100
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide association study of metabolic dysfunction-associated fatty liver disease in a Korean population.
Lee Y; Cho EJ; Choe EK; Kwak MS; Yang JI; Oh SW; Yim JY; Chung GE
Sci Rep; 2024 Apr; 14(1):9753. PubMed ID: 38679617
[TBL] [Abstract][Full Text] [Related]
20. Increased parenchymal damage and steatohepatitis in Caucasian non-alcoholic fatty liver disease patients with common IL1B and IL6 polymorphisms.
Nelson JE; Handa P; Aouizerat B; Wilson L; Vemulakonda LA; Yeh MM; Kowdley KV;
Aliment Pharmacol Ther; 2016 Dec; 44(11-12):1253-1264. PubMed ID: 27730688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
